New Belgian Innovation Office To Accelerate Availability of Novel Medicines
The Belgian medicines agency's innovation office will initially focus on providing support to SMEs and academia developing innovative medicines, and then move on to other tasks, such as providing iterative scientific advice, pre-submission guidance and early-phase regulatory advice to drug sponsors.
You may also be interested in...
The newly established EU Innovation Network aims to increase the visibility of the support being offered by national competent authorities to innovative medicinal products in member states, and help boost the delivery of novel medicines to patients.
Revisions to the updated EU guideline on transitioning multinational trials to the Clinical Trials Regulation are said to be “solution oriented.”
The European Medicines Agency is consulting on major changes to its decade-old guidance on the development of medicinal products for acute and long-term treatment of major depressive disorder.